Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death.

被引：0
|
作者：
Sanford, Nina Niu
Chen, Ming-Hui
Loffredo, Marian J.
Renshaw, Andrew A.
Kantoff, Philip W.
D'Amico, Anthony Victor
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Univ Connecticut, Dept Stat, Storrs, CT USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Baptist Hosp Miami, Miami, FL USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5070
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Duration of the Anti-Androgen in Men Undergoing 6 Months of an LHRH Agonist and Radiation Therapy for Unfavorable-Risk Prostate Cancer and the Risk of Death
    Sanford, N. N.
    Chen, M. H.
    Loffredo, M.
    Renshaw, A.
    Kantoff, P. W.
    D'Amico, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E226 - E227
  • [2] Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
    N N Sanford
    M-H Chen
    M Loffredo
    A Renshaw
    P W Kantoff
    A V D'Amico
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 79 - 84
  • [3] Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
    Sanford, N. N.
    Chen, M-H
    Loffredo, M.
    Renshaw, A.
    Kantoff, P. W.
    D'Amico, A. V.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (01) : 79 - 84
  • [4] Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable-risk prostate cancer
    Dyer, Michael A.
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    JOURNAL OF RADIATION ONCOLOGY, 2016, 5 (03) : 293 - 300
  • [5] Stereotactic body radiation therapy with androgen deprivation therapy for unfavorable-risk prostate cancer
    Patel, Sagar Anil
    Switchenko, Jeffrey M.
    Zhang, Chao
    Rose, Brent Shane
    Fischer-Valuck, Benjamin Walker
    Jani, Ashesh B.
    Chen, Ronald C.
    Royce, Trevor Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone
    Mai Anh Huynh
    Chen, Ming-Hui
    Wu, Jing
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (04): : 1158 - 1167
  • [7] The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
    Patel, S. A.
    Chen, M-H
    Loffredo, M.
    Renshaw, A.
    Kantoff, P. W.
    D'Amico, A. V.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (02) : 234 - 240
  • [8] The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
    S A Patel
    M-H Chen
    M Loffredo
    A Renshaw
    P W Kantoff
    A V D'Amico
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 234 - 240
  • [9] Percent positive biopsy cores and the risk of death from prostate cancer in men with unfavorable-risk prostate cancer
    Phillips, John G.
    Chen, Ming-Hui
    Zhang, Danjie
    Loffredo, Marian
    Kantoff, Philip W.
    D'Amico, Anthony V.
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (03) : 307 - 312
  • [10] Gleason score and the risk of cause-specific and overall mortality following radiation with or without 6 months of androgen deprivation therapy for men with unfavorable-risk prostate cancer.
    Warren, Laura Elizabeth
    Chen, Ming-Hui
    Denham, James William
    Steigler, Allison
    Renshaw, Andrew A.
    Loffredo, Marian J.
    Kantoff, Philip W.
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345